@misc{indiciaea98591851fde,
  title = {Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases},
  author = {Shemorry, A. and den Besten, W. and Mulvihill, M. M. and Essenburg, C. J. and Blaquiere, N. and Kleinheinz, T. and Villemure, E. and Peale, F. and Deshmukh, G. and Maddalo, D. and Levy, E. and Yu, K. and Tovar, E. A. and Wolfrum, E. and Blake, R. A. and Nagapudi, K. and Forrest, W. F. and Staben, S. T. and Graveel, C. R. and Fairbrother, W. J. and Wertz, I. E.},
  year = {2024},
  doi = {10.1101/2024.06.09.595178},
  url = {https://www.biorxiv.org/content/10.1101/2024.06.09.595178v1},
  note = {Source identifier: 10.1101/2024.06.09.595178}
}